Kangmei Pharma | 600518 - Interest Expense On Debt

Stock Price
1.88
Daily Change
0.01 0.53%
Monthly
-1.57%
Yearly
-14.93%
Q1 Forecast
1.84

Kangmei Pharma reported CNY1.82M in Interest Expense on Debt for its fiscal quarter ending in September of 2025.





Interest Expense On Debt Change Date
Akebia Therapeutics 364.15M 18.56M Sep/2025
Alaunos Therapeutics USD 0 0 Dec/2023
Avita Medical AUD 1.25M 100K Jun/2025
Cspc Pharmaceutical CNY 10.19M 4.73M Sep/2025
Dianthus Therapeutics USD 4.44M 263K Sep/2024
Genomma Lab Internacional MXN 190.68M 972K Dec/2025
Hypermarcas BRL 40.29M 212.89M Sep/2025
Ionis Pharmaceuticals USD 18M 0 Dec/2025
IQVIA Holdings USD 193M 4M Dec/2025
Jiangsu Hengrui CNY 254.59M 253.85M Sep/2025
Kangmei Pharma CNY 1.82M 150K Sep/2025
Moderna USD 12.14B 12.13B Sep/2025
Organon & Co USD 128M 3M Sep/2025
Revvity USD 23.51M 742K Dec/2025
Sh Fosun Pharma CNY 321.25M 2M Sep/2025
Tectonic Therapeutic USD 277M 276.98M Sep/2025
Viatris USD 119.6M 0 Dec/2025
Wuxi Apptec CNY 103.05M 37.29M Jun/2025
Xeris Pharmaceuticals USD 7.27M 92K Sep/2025
Zz Pientze Pharmaceu CNY 46.05M 36.5M Jun/2025